Ron Do

Ron Do

Auto-generated profile, based on publicly available information

Ron Do

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 August 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CTCatherine Tcheandjieu
Catherine Tcheandjieu
XZXiang Zhu
Xiang Zhu
AHAustin T. Hilliard
Austin T. Hilliard
SCShoa L. Clarke
Shoa L. Clarke
Valerio NapolioniValerio Napolioni
Valerio Napolioni
MPMillion Veteran Program
Million Veteran Program

2 July 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MVMarie Verbanck
Marie Verbanck
CCChia-Yen Chen
Chia-Yen Chen
BNBenjamin Neale
Benjamin Neale
RDRon Do
Ron Do
In the version of this article initially published, the Supplementary Text and Figures file was missing Supplementary Tables 4, 6, 8 and 10–14. The correct file has now been provided online.

20 December 2022 in The Lancet
Verified
Journal Article
Closed access
IFIain S Forrest
Iain S Forrest
BPBen O Petrazzini
Ben O Petrazzini
ÁDÁine Duffy
Áine Duffy
JPJoshua K Park
Joshua K Park
CMCarla Marquez-Luna
Carla Marquez-Luna
RDRon Do
Ron Do

14 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMichael G. Levin
Michael G. Levin
NTNoah L. Tsao
Noah L. Tsao
PSPankhuri Singhal
Pankhuri Singhal
CLChang Liu
Chang Liu
HVHa My T. Vy
Ha My T. Vy
SDScott M. Damrauer
Scott M. Damrauer
Heart failure is a leading cause of cardiovascular morbidity and mortality. However, the contribution of common genetic variation to heart failure risk has not been fully elucidated, particularly in comparison to other common cardiometabolic traits. We report a multi-ancestry genome-wide association study meta-analysis of all-cause heart failure including up to 115,150 cases and 1,550,331 controls of diverse genetic ancestry, identifying 47 risk loci. We also perform multivariate genome-wide association studies that integrate heart failure with related cardiac magnetic resonance imaging endophenotypes, identifying 61 risk loci. Gene-prioritization analyses including colocalization and transcriptome-wide association studies identify known and previously unreported candidate cardiomyopathy genes and cellular processes, which we validate in gene-expression profiling of failing and healthy human hearts. Colocalization, gene expression profiling, and Mendelian randomization provide convergent evidence for the roles of BCKDHA and circulating branch-chain amino acids in heart failure and cardiac structure. Finally, proteome-wide Mendelian randomization identifies 9 circulating proteins associated with heart failure or quantitative imaging traits. These analyses highlight similarities and differences among heart failure and associated cardiovascular imaging endophenotypes, implicate common genetic variation in the pathogenesis of heart failure, and identify circulating proteins that may represent cardiomyopathy treatment targets.

29 May 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MHMichael C. Honigberg
Michael C. Honigberg
BTBuu Truong
Buu Truong
RKRaiyan R. Khan
Raiyan R. Khan
BXBrenda Xiao
Brenda Xiao
LBLaxmi Bhatta
Laxmi Bhatta
PNPradeep Natarajan
Pradeep Natarajan